Profile image
Story Views

Last Hour:
Last 24 Hours:

Infectious Disease Treatment Market 2016 Trend, Analysis and Overview

Thursday, March 16, 2017 2:29
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Infectious diseases are caused by pathogenic microorganisms such as bacteria, parasites, fungi, or viruses. They can be transmitted from one person to another through direct or indirect contact. Anti-infective drugs are used to kill (cidal) or stop the growth (static) of infectious agents. Based on target organism, anti-infective drugs can be categorized into antibacterial, antifungal, antiviral, and antiparasitic. 

Publisher’s analysts forecast the infectious disease treatment market in China to grow at a CAGR of 5.01% during the period 2016-2020.

For more information about this report:                                                 

Covered in this report 
The report covers the present scenario and the growth prospects of the infectious disease treatment market in China for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat infectious diseases. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

Publisher’s report, Infectious Disease Treatment Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- F. Hoffmann-La Roche
- Gilead Sciences
- Johnson & Johnson
- Merck
- Pfizer 


Request Sample Copy at                                    


Other prominent vendors 
- Achaogen
- Actelion
- Adenovir Pharma
- AstraZeneca
- Bayer
- Biocryst
- Celsus therapeutics
- Cempra
- Eleven Biotherapeutics
- Exoxemis
- Ferrer International
- Griffin Discoveries
- Hexima
- InSite Vision
- Insmed Incorporated
- KaloBios Pharmaceuticals
- Lytix Biopharma
- Meiji Seika Pharma
- Melinta Therapeutics
- Moberg Pharma
- NanoViricides
- Nektar
- NicOx
- NovaBay
- NovaBiotics
- Ocular Therapeutix
- Panoptes Pharma
- Paratek Pharmaceuticals
- Polichem
- PTC Therapeutics
- RedHill
- Shire
- Starpharma Holdings
- Sun Pharma
- Symbiomix
- Tetraphase Pharmaceuticals
- The Medicines Company
- Theravance Biopharma
- Topica Pharmaceuticals
- Vertex Pharmaceuticals
- Viamet Pharmaceuticals

Inquire for Report at   

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.